A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy Individuals.

Nathan B ErdmannWilton B WilliamsStephen R WalshNicole GrunenbergPaul T EdlefsenPaul A GoepfertDerek W CainKristen W CohenJanine MaenzaKenneth H MayerHong Van TieuMagdalena E SobieszczykEdith SwannHuiyin LuStephen C De RosaZachary SagawaM Anthony MoodyChristopher B FoxGuido FerrariR J EdwardsPriyamvada AcharyaS Munir AlamRobert ParksMargaret BarrGeorgia D TomarasDavid C MontefioriPeter B GilbertM Juliana McElrathLawrence CoreyBarton F HaynesLindsey R Badennull null

Published in: medRxiv : the preprint server for health sciences (2024)

http://www.clinicaltrials.gov/ Identifier: NCT03934541.

Keyphrases

antiretroviral therapy
hiv positive
hiv infected
hiv testing
human immunodeficiency virus
hepatitis c virus
hiv aids
men who have sex with men
cancer therapy
dengue virus
monoclonal antibody
south africa